Jonathan Dickinson serves as the Chief Executive Officer of Innate Pharma, having assumed leadership of the clinical-stage biopharmaceutical enterprise. Bringing extensive executive leadership experience acquired through senior operational roles at prominent global oncology and biopharmaceutical organizations—including Incyte, Hoffmann-La Roche, and Bristol-Myers Squibb—he directs the company's overarching corporate strategy, clinical trial execution, global partnerships, and the advancement of its next-generation oncology pipeline.